Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedAdded: These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study; Revision: v3.3.2. Deleted: These publications come from PubMed, this list is automatically created by ClinicalTrials.gov Identifier (NCT Number), and these articles may or may not be about the study; Revision: v3.2.0.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved a site-wide notice about government funding and NIH Clinical Center operations. No study data or requirements were changed.SummaryDifference0.3%

- Check48 days agoChange DetectedResults data for the study were added and posted, including primary and secondary outcomes. The Study Record Dates show the results submission and posting.SummaryDifference0.4%

- Check69 days agoChange Detected- Added a government-operating-status notice and a current operating status link, and - updated the revision version from v3.1.0 to v3.2.0. No other substantive content changes were detected.SummaryDifference2%

- Check77 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new software version.SummaryDifference0.0%

- Check92 days agoChange DetectedPage revision updated to v3.0.2 and Back to Top UI element removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.